Randomized Study of Alendronate in Adult Patients With Cystic Fibrosis Related Osteoporosis

Completed · Not applicable

Conditions studied: Osteoporosis, Cystic Fibrosis

In brief

OBJECTIVES: I. Determine the bioavailability and biologic effect of alendronate on bone metabolism in patients with cystic fibrosis. II. Assess the safety and efficacy of this treatment regimen in improving osteoporosis in this patient population.

Key facts

Study ID

NCT00004489

Run by

University of North Carolina

People needed

60

Starts

1998-10-01

Expected to finish

2002-09-01

Last updated by the study team

2015-03-25

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: not accepted.

Where it is running

• University of North Carolina School of Medicine — Chapel Hill, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.